Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Myszkowski Kenneth Allen
Chief Financial Officer at ARROWHEAD PHARMACEUTICALS. Filing since 27 Aug 2010.
CIK 0001486672
Company
Date
Role
Action
Shares
Amount
Of holding
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
7 Jan 2025
Chief Financial Officer
Sold on a plan
18,000
$354.50K
3.8%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Jan 2025
Chief Financial Officer
Sold on a plan
27,167
$538.60K
5.4%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Mar 2024
Chief Financial Officer
Sold at will
40,000
$1.41M
9.1%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2024
Chief Financial Officer
Sold on a plan
16,104
$567.91K
3.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
27 Jun 2023
Chief Financial Officer
Sold at will
15,000
$543.00K
3.8%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
29 Dec 2022
Chief Financial Officer
Sold, plan not stated
30,625
$1.23M
8.3%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2022
Chief Financial Officer
Sold, plan not stated
40,000
$2.47M
7.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
12 Jan 2021
Chief Financial Officer
Sold, plan not stated
1,441
$116.72K
0.3%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
11 Jan 2021
Chief Financial Officer
Sold, plan not stated
11,597
$939.59K
2.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Jan 2021
Chief Financial Officer
Sold, plan not stated
30,625
$2.22M
6.3%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
9 Nov 2020
Chief Financial Officer
Sold, plan not stated
43,505
$3.02M
9.2%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
20 Oct 2020
Chief Financial Officer
Sold, plan not stated
29,166
$1.58M
6.4%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
21 Jan 2020
Chief Financial Officer
Sold, plan not stated
40,313
$1.99M
9.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Jan 2020
Chief Financial Officer
Sold, plan not stated
20,000
$1.20M
4.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
1 Nov 2019
Chief Financial Officer
Sold, plan not stated
37,884
$1.55M
10.8%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
21 May 2019
Chief Financial Officer
Sold, plan not stated
27,071
$595.56K
8.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
19 Feb 2019
Chief Financial Officer
Sold, plan not stated
8,000
$144.00K
2.6%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
17 Jan 2019
Chief Financial Officer
Sold, plan not stated
81,875
$1.19M
21.1%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
2 Jan 2019
Chief Financial Officer
Sold, plan not stated
8,333
$99.83K
2.1%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Sep 2018
Chief Financial Officer
Sold, plan not stated
45,000
$870.20K
12.6%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
19 Jun 2018
Chief Financial Officer
Sold, plan not stated
20,000
$280.20K
6.0%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
31 May 2018
Chief Financial Officer
Sold, plan not stated
12,600
$138.60K
3.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
30 May 2018
Chief Financial Officer
Sold, plan not stated
1,400
$15.40K
0.4%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
27 Mar 2018
Chief Financial Officer
Sold, plan not stated
20,000
$160.00K
6.0%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
23 Aug 2016
Chief Financial Officer
Sold, plan not stated
6,900
$55.20K
5.6%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
22 Aug 2016
Chief Financial Officer
Sold, plan not stated
13,100
$104.80K
10.2%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
30 Dec 2015
Chief Financial Officer
Sold, plan not stated
23,347
$143.12K
21.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
15 Aug 2014
CFO
Sold, plan not stated
40,000
$560.86K
35.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
12 Feb 2014
CFO
Sold, plan not stated
16,000
$300.29K
18.3%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
27 Aug 2010
CFO
Bought
15,000
$13.35K
opened
30 decisions on file.
